The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Aclaris Therapeutics Inc shares valued at $7,500 were purchased by Powell Andrew Kenneth William on Mar 04 ’24. At $1.25 per share, Powell Andrew Kenneth William acquired 6,000 shares. The insider’s holdings grew to 28,863 shares worth approximately $35501.49 following the completion of this transaction.
Also, Powell Andrew Kenneth William purchased 8,500 shares, netting a total of over 10,455 in proceeds. Following the buying of shares at $1.23 each, the insider now holds 22,863 shares.
Before that, Monahan Joseph had sold 6,000 shares from its account. In a trade valued at $30,460, the Chief Scientific Officer traded Aclaris Therapeutics Inc shares for $5.08 each. Upon closing the transaction, the insider’s holdings decreased to 6,000 shares, worth approximately $0.16 million.
As published in a research note from H.C. Wainwright on January 22, 2024, Aclaris Therapeutics Inc [ACRS] has been rated down from a Buy to a Neutral. Analysts at William Blair downgraded the stock from ‘”an Outperform”‘ to ‘”a Mkt perform”‘ outlook in a report released in mid November. As of October 03, 2023, Evercore ISI has initiated its “an Outperform” rating for ACRS. Earlier on December 14, 2022, Stifel initiated its rating. Their recommendation was “a Buy” for ACRS stock.
Analyzing ACRS Stock Performance
During the last five days, there has been a surge of approximately 6.03%. Over the course of the year, Aclaris Therapeutics Inc shares have jumped approximately 17.14%. Shares of the company reached a 52-week high of $1.5100 on 03/06/24 and a 52-week low of $0.8555 on 01/12/24. A 50-day SMA is recorded $1.2150, while a 200-day SMA reached $4.0953. Nevertheless, trading volume fell to 0.56 million shares from 1.07 million shares the previous day.
Support And Resistance Levels for Aclaris Therapeutics Inc (ACRS)
According to the 24-hour chart, there is a support level at 1.2123, which, if violated, would cause prices to drop to 1.1947. In the upper region, resistance lies at 1.2488. The next price resistance is at 1.2677. RSI (Relative Strength Index) is 52.33 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0043, which suggests the price will decrease in the coming days. Percent R is at 52.94%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
